News
A nationwide Danish cohort study demonstrated no increased risk of serious adverse events following vaccination with JN.1-updated mRNA COVID-19 vaccines, reinforcing their safety profile and ...
CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission ...
In a memo, CEO Stéphane Bancel said the job cuts are needed to align the struggling vaccine maker’s cost structure with the ...
The Covid-19 pandemic turned Moderna and BioNTech into household names almost overnight. Now the two companies find ...
There have been lots of changes to COVID vaccine recommendations. Here is the current vaccine schedule for people 6 months to 65+ years old.
1d
Zacks Investment Research on MSNMerck Unveils Cost-Cutting Plan: Can it Create Long-Term Value?Along with its second-quarter results on July 29, Merck MRK announced a new multi-year optimization initiative, which is ...
The new vaccinations could be self-administered at home, with the floss approach also thought compatible with flu, hepatitis ...
Robert F. Kennedy Jr. announces plans to reform the Vaccine Injury Compensation Program, addressing claims of inefficiency ...
2d
Zacks Investment Research on MSNModerna to Report Q2 Earnings: Is a Beat in Store for the Stock?We expect Moderna MRNA to surpass expectations when it reports second-quarter 2025 earnings on Aug. 1, before the opening ...
The multi-year effort comes as Merck prepares to offset revenue losses from the upcoming patent expiration of its blockbuster cancer drug Keytruda.
Updated Vaccine Recommendations Earlier this week, Secretary Kennedy announced in a social media video that the recommendation for COVID vaccination of a "pregnant woman has been removed from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results